Qyuns Therapeutics

Provider of drug development services to biopharma sector

placeTaizhou, Jiangsu, China calendar_todayFounded 2015 groups313 employees language qyuns.net

Innovation

15 patent families (8 granted) — focus: Chemistry & metallurgy, Human necessities, Physics & computing; filing pace steady. Cited 739 times.

YearFilings
20172
20181
20202
20212
20225
20238
20245
20258
20262

Investor mix

7 investors on record; lead investors include Shenzhen Ruixiangyuan Fund Management, Matrix Partners China.

Investor typeCountShare
Venture capital571%
Private equity229%
Coming soon